Combination Chemotherapy Alone Should Be Used in the Treatment of Patients With Stage IV EGFR-Mutant NSCLC Whose Disease Has Progressed on All Available Tyrosine Kinase Inhibitors.
2021
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
13
References
1
Citations
NaN
KQI